# ArriVent BioPharma, Inc.: Form 8-K, filed Sep 9, 2024

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: 8-K
- Filed: 2024-09-09
- Accepted by EDGAR: Sep 9, 2024, 12:15 ET
- Period: 2024-09-09
- Accession: 0001104659-24-098059
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000110465924098059/tm2423588d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000110465924098059/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000110465924098059/tm2423588d1_8k.htm

Filed Sep 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-098059. Last ingested by Listed: Nov 10, 2026, 02:46 ET. No prices; not investment advice.
